Computer navigation leads to more accurate glenoid targeting during Total Shoulder Arthroplasty (TSA) compared with three-dimensional (3D) preoperative planning alone.
The FDA approved the use of the reverse shoulder prosthesis in the United States in 2004, nearly 25 years following its re-debut in France.
Instability and scapular stress fractures remain two of the most common complications after reverse Total Shoulder Arthroplasty (rTSA), both of which may compromise outcomes and require further surgery.
Acromial Fracture: An Uncommon but Increasingly Preventable Complication After Reverse Shoulder Replacement
The reverse shoulder prosthesis was introduced in France in the 1980s and was FDA-approved for use in the United States in 2004. Since that time, it has revolutionized the field of shoulder replacement.
When Dr. Paul Grammont introduced the reverse total shoulder arthroplasty (rTSA) in the late 1980s/early 1990s, it was a revolutionary treatment for a previously unsolved clinical condition, rotator cuff tear arthropathy.
In 2013, Dr. Carlo Romano presented clinical evidence for InterSpace via a systematic review of globally accumulated literature.
Accurate placement of the glenoid component in reverse total shoulder arthroplasty (rTSA) is important to reduce component loosening, scapular notching, instability and to maximize impingement-free range of motion.